MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $705,000 | +72.0% | 11,695 | +31.2% | 0.01% | +66.7% |
| Q1 2016 | $410,000 | +113.5% | 8,915 | +123.9% | 0.00% | +200.0% |
| Q4 2015 | $192,000 | -46.4% | 3,982 | -52.7% | 0.00% | -66.7% |
| Q3 2015 | $358,000 | +3.8% | 8,417 | +178.6% | 0.00% | 0.0% |
| Q2 2015 | $345,000 | +13.5% | 3,021 | +28.4% | 0.00% | +50.0% |
| Q1 2015 | $304,000 | +31.0% | 2,352 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $232,000 | -12.8% | 2,326 | -13.4% | 0.00% | 0.0% |
| Q3 2014 | $266,000 | +25.5% | 2,687 | -2.4% | 0.00% | 0.0% |
| Q2 2014 | $212,000 | +1.4% | 2,754 | -15.0% | 0.00% | 0.0% |
| Q1 2014 | $209,000 | +16.8% | 3,241 | +15.5% | 0.00% | 0.0% |
| Q4 2013 | $179,000 | -68.5% | 2,807 | -70.4% | 0.00% | -60.0% |
| Q3 2013 | $568,000 | +126.3% | 9,482 | +86.2% | 0.01% | +150.0% |
| Q2 2013 | $251,000 | – | 5,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |